NeuroSense Regains Nasdaq Compliance

BenzingaSep 24 21:07

Express News | Neurosense Therapeutics Ltd: Patent Protection Extends Through 2042, Adding 4 Additional Years to Primec's Ip Umbrella

BreakingsSep 24 21:05

Express News | Neurosense Therapeutics Granted Key U.S. Patent for Novel Primec Formulation, Its Lead Asset for ALS and Alzheimer's

BreakingsSep 24 21:05

NeuroSense Therapeutics Granted Key U.S. Patent for Novel PrimeC Formulation, Its Lead Asset for ALS and Alzheimer's

PR NewswireSep 24 21:05

NeuroSense Regains Compliance With NASDAQ Minimum Bid Price Rule

PRNewswireSep 24 21:00

Express News | Neurosense Therapeutics - Positive Results Align With Co' S Regulatory Strategy, Reinforce Long-Term Safety Profile of Drug Candidate Primec

BreakingsSep 9 18:13